Medication info
Rosabesil Tablet 5/100 mg (Amlodipine, Losartan Potassium)

Rosabesil Tablet 5/100 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
Light pink, rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202002054 · Approved 2020.03.24 · Insurance code 073000590

Summary

Main use
Control of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or losartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Administration of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this drug as initial treatment is not recommended.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, administration of this drug is not recommended.

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Control of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medicine is used for patients with essential hypertension whose blood pressure control is insufficient with monotherapy of amlodipine or losartan. It is also used as an initial treatment for stage 2 hypertension patients who require combination therapy to reach the target blood pressure. This helps effectively manage blood pressure and improves hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose of each individual component (amlodipine or losartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Administration of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this drug as initial treatment is not recommended.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, administration of this drug is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. It may also pose risks to the fetus if taken in early pregnancy; therefore, women who may become pregnant should consult with a doctor. Patients with decreased effective blood volume, particularly those on diuretics, may experience symptoms of hypotension when first taking this medication, so caution is necessary. This medication should not be given to patients allergic to its active ingredients or related components, patients with severe liver dysfunction, severe aortic stenosis, or those in a state of shock. Patients with high potassium levels in the blood, severe kidney impairment, and those on strict salt restrictions should use this medication cautiously and require regular monitoring. This medication may cause side effects such as dizziness or drowsiness, so caution should be exercised when performing hazardous tasks like operating machinery or driving. Patients with impaired liver or kidney function should adjust the dosage or avoid use of this medication. If used with other antihypertensive agents, blood pressure may drop too low, so it should be taken as directed by a physician. This medication should be avoided with grapefruit juice as it may increase blood concentration. It is safest for pregnant or breastfeeding women to avoid this medication, and those planning pregnancy or suspecting they may be pregnant should consult with healthcare professionals. Safety and efficacy for pediatric and adolescent patients have not been established, so its use is not recommended. Elderly patients may require initial dose adjustments, so they should follow the instructions of their healthcare provider. In cases of overdose, severe hypotension and cardiac issues can occur, so immediate medical attention is required. This medication should be stored out of reach of children, and it is advisable not to transfer the medication to another container.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 184 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • shortness of breath
  • cough
  • conjunctival injection
  • frequent urination
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory decrease
  • dysesthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urological disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • erythematous rash
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • facial edema
  • fever
  • orthostatic effects
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • reduced libido
  • memory impairment
  • migraine
  • neurogenic hyperexcitability
  • panic disorder
  • sleep disorders
  • tremor
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • decreased vision
  • nocturia
  • urinary tract infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylaxis syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to ensure the medication’s effectiveness is preserved safely.

Appearance and packaging

Appearance

Light pink, rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.